Bioequivalence Study of Tiotropium Bromide Inhalation Powder
Clinical trial NCT05161156 · COMPLETED
Trial details
- NCT number
- NCT05161156
- Sponsor
- Phargentis SA
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-24
- Primary completion
- 2022-11-29
- Enrollment
- 306
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.